These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22340557)

  • 21. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomics of tumor-specific proteins in cerebrospinal fluid of patients with astrocytoma: usefulness of gelsolin protein.
    Ohnishi M; Matsumoto T; Nagashio R; Kageyama T; Utsuki S; Oka H; Okayasu I; Sato Y
    Pathol Int; 2009 Nov; 59(11):797-803. PubMed ID: 19883430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cathepsin D is secreted from M-BE cells: its potential role as a biomarker of lung cancer.
    Lou X; Xiao T; Zhao K; Wang H; Zheng H; Lin D; Lu Y; Gao Y; Cheng S; Liu S; Xu N
    J Proteome Res; 2007 Mar; 6(3):1083-92. PubMed ID: 17284061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
    Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
    Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer.
    Bai Z; Ye Y; Liang B; Xu F; Zhang H; Zhang Y; Peng J; Shen D; Cui Z; Zhang Z; Wang S
    Int J Oncol; 2011 Feb; 38(2):375-83. PubMed ID: 21165559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis.
    Liu W; Liu B; Xin L; Zhang Y; Chen X; Zhu Z; Lin Y
    Clin Chim Acta; 2007 Feb; 377(1-2):119-26. PubMed ID: 17067565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteome analysis of responses to ascochlorin in a human osteosarcoma cell line by 2-D gel electrophoresis and MALDI-TOF MS.
    Kang JH; Park KK; Lee IS; Magae J; Ando K; Kim CH; Chang YC
    J Proteome Res; 2006 Oct; 5(10):2620-31. PubMed ID: 17022633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
    Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
    Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer.
    Chen Y; Zhang H; Xu A; Li N; Liu J; Liu C; Lv D; Wu S; Huang L; Yang S; He D; Xiao X
    Lung Cancer; 2006 Oct; 54(1):95-102. PubMed ID: 16890323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma.
    Li Y; Dang TA; Shen J; Perlaky L; Hicks J; Murray J; Meyer W; Chintagumpala M; Lau CC; Man TK
    Proteomics; 2006 Jun; 6(11):3426-35. PubMed ID: 16673437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative proteomic analysis of human osteosarcoma and SV40-immortalized normal osteoblastic cell lines.
    Guo QC; Shen JN; Jin S; Wang J; Huang G; Zhang LJ; Huang G; Yin JQ; Zou CY; Li MT
    Acta Pharmacol Sin; 2007 Jun; 28(6):850-8. PubMed ID: 17506944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
    Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L
    Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis.
    Blanco-Colio LM; Martín-Ventura JL; Muñóz-García B; Orbe J; Páramo JA; Michel JB; Ortiz A; Meilhac O; Egido J
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):916-22. PubMed ID: 17272745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The level of vascular endothelial growth factor as a predictor of a poor prognosis in osteosarcoma.
    Kaya M; Wada T; Nagoya S; Sasaki M; Matsumura T; Yamashita T
    J Bone Joint Surg Br; 2009 Jun; 91(6):784-8. PubMed ID: 19483233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Separation and identification of differentially expressed nuclear matrix proteins in breast carcinoma forming.
    He Q; Zhang SQ; Chu YL; Jia XL; Zhao LH; Wang XL
    Acta Oncol; 2010; 49(1):76-84. PubMed ID: 19878069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum proteomic profiling reveals that pretreatment complement protein levels are predictive of esophageal cancer patient response to neoadjuvant chemoradiation.
    Maher SG; McDowell DT; Collins BC; Muldoon C; Gallagher WM; Reynolds JV
    Ann Surg; 2011 Nov; 254(5):809-16; discussion 816-7. PubMed ID: 22005152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic-based analysis for identification of potential serum biomarkers in gallbladder cancer.
    Tan Y; Ma SY; Wang FQ; Meng HP; Mei C; Liu A; Wu HR
    Oncol Rep; 2011 Oct; 26(4):853-9. PubMed ID: 21687958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of platelet proteins separated by two-dimensional gel electrophoresis and analyzed by matrix assisted laser desorption/ionization-time of flight-mass spectrometry and detection of tyrosine-phosphorylated proteins.
    Marcus K; Immler D; Sternberger J; Meyer HE
    Electrophoresis; 2000 Jul; 21(13):2622-36. PubMed ID: 10949139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dynamic changes of serum proteomic spectra in patients with non-Hodgkin's lymphoma (NHL) before and after chemotherapy and screening of candidate biomarkers for NHL].
    Ling JY; Sun XF; Zhang X; Zhen ZJ; Xia Y; Luo WB; Lin H; Zheng L
    Ai Zheng; 2008 Oct; 27(10):1065-9. PubMed ID: 18851786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
    Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
    Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.